US clinical trials: devices industry forearms on disclosure issue
This article was originally published in Clinica
Executive Summary
The US device industry is bracing itself for the possibility that it could be caught up in the fall-out of the growing controversy over whether pharmaceutical companies are fully disclosing details of their clinical trials.